SCHEMBL828805

SCHEMBL828805

O=C1C[CH]N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5080175 0.75
SCHEMBL1062405 0.75
SCHEMBL75552 0.72
SCHEMBL16058947 0.68
SCHEMBL10369835 0.66
SCHEMBL3282168 0.65
SCHEMBL10368605 0.65
SCHEMBL7432250 0.65 CRBN (0.39)
SCHEMBL3108626 0.63
SCHEMBL21543812 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4399209-A1 NEW QUINOLINE DERIVATIVES Elanco Animal Health GmbH (DE) 2024-07-17 EP claimed
CN-117957223-A Quinoline derivatives 礼蓝动物保健有限公司 2024-04-30 CN claimed
WO-2023036821-A1 NEW QUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-03-16 WO claimed
EP-4148052-A1 NEW QUINOLINE DERIVATIVES Bayer Animal Health GmbH (DE) 2023-03-15 EP claimed
US-8557801-B2 Compounds and compositions useful for the treatment of parasitic diseases IRM LLC (BM) 2013-10-15 US claimed
EP-2451814-A2 FUSED IMIDAZOLES AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS E.G. MALARIA IRM LLC (BM) 2012-05-16 EP claimed
US-20110059934-A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF PARASITIC DISEASES IRM LLC (BM) 2011-03-10 US claimed
WO-2011006143-A2 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES IRM LLC (BM) 2011-01-13 WO claimed
US-20040029920-A1 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives KUDUK SCOTT D (US) 2004-02-12 US claimed
CN-1026786-C Anti-fungal triazole derivatives, their preparation and uses SANKYO CO (JP) 1994-11-30 CN claimed
EP-0406119-B1 New peptide derivatives, process of their preparation and pharmaceutical compositions containing them ADIR (FR) 1994-01-19 EP claimed
US-5098888-A Cholinergic agents and antispasmodic agents ADIR ET COMPAGNIE (FR) 1992-03-24 US claimed
EP-0473387-A2 Anti-fungal triazole derivatives, their preparation and uses Sankyo Company Limited (JP) 1992-03-04 EP claimed
EP-0252885-A1 Bicyclic thiaaza compounds CIBA-GEIGY AG (CH) 1988-01-13 EP claimed
EP-4399209-A1 NEW QUINOLINE DERIVATIVES Elanco Animal Health GmbH (DE) 2024-07-17 EP disclosed
CN-117957223-A Quinoline derivatives 礼蓝动物保健有限公司 2024-04-30 CN disclosed
WO-2023036821-A1 NEW QUINOLINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2023-03-16 WO disclosed
EP-0473387-A2 Anti-fungal triazole derivatives, their preparation and uses Sankyo Company Limited (JP) 1992-03-04 EP disclosed
EP-0252885-A1 Bicyclic thiaaza compounds CIBA-GEIGY AG (CH) 1988-01-13 EP disclosed
EP-0008899-A1 Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1980-03-19 EP disclosed